Alder Biopharmaceuticals Stock Operating Margin
Alder BioPharmaceuticals fundamentals help investors to digest information that contributes to Alder BioPharmaceutica's financial success or failures. It also enables traders to predict the movement of Alder Stock. The fundamental analysis module provides a way to measure Alder BioPharmaceutica's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Alder BioPharmaceutica stock.
Alder |
Alder BioPharmaceuticals Company Operating Margin Analysis
Alder BioPharmaceutica's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Alder BioPharmaceutica Operating Margin | (7.69) % |
Most of Alder BioPharmaceutica's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Alder BioPharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
CompetitionBased on the recorded statements, Alder BioPharmaceuticals has an Operating Margin of -7.685039%. This is 78.09% lower than that of the Healthcare sector and 93.14% lower than that of the Biotechnology industry. The operating margin for all United States stocks is 39.47% higher than that of the company.
Alder Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Alder BioPharmaceutica's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Alder BioPharmaceutica could also be used in its relative valuation, which is a method of valuing Alder BioPharmaceutica by comparing valuation metrics of similar companies.Alder BioPharmaceutica is currently under evaluation in operating margin category among related companies.
Alder Fundamentals
| Return On Equity | -1.42 | |||
| Return On Asset | -100.86 | |||
| Profit Margin | 15.82 % | |||
| Operating Margin | (7.69) % | |||
| Current Valuation | 1.46 B | |||
| Shares Outstanding | 83.64 M | |||
| Shares Owned By Insiders | 5.20 % | |||
| Shares Owned By Institutions | 94.80 % | |||
| Number Of Shares Shorted | 12.05 M | |||
| Price To Earning | (2.18) X | |||
| Price To Book | 14.15 X | |||
| Price To Sales | 1,808 X | |||
| Revenue | 936 K | |||
| Gross Profit | (161.99 M) | |||
| EBITDA | (343.46 M) | |||
| Net Income | (322.8 M) | |||
| Cash And Equivalents | 409.31 M | |||
| Cash Per Share | (3.62) X | |||
| Total Debt | 193.36 M | |||
| Debt To Equity | 89.10 % | |||
| Current Ratio | 8.94 X | |||
| Book Value Per Share | 1.99 X | |||
| Cash Flow From Operations | (258.2 M) | |||
| Short Ratio | 2.19 X | |||
| Earnings Per Share | (4.40) X | |||
| Price To Earnings To Growth | (0.20) X | |||
| Number Of Employees | 202 | |||
| Beta | 2.95 | |||
| Market Capitalization | 1.58 B | |||
| Total Asset | 443.6 M | |||
| Retained Earnings | (890.37 M) | |||
| Working Capital | 411.26 M | |||
| Current Asset | 428.01 M | |||
| Current Liabilities | 16.75 M | |||
| Z Score | 3.4 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Alder BioPharmaceutica in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Alder BioPharmaceutica's short interest history, or implied volatility extrapolated from Alder BioPharmaceutica options trading.
Pair Trading with Alder BioPharmaceutica
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alder BioPharmaceutica position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alder BioPharmaceutica will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to PGE Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace PGE Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back PGE Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling PGE Corp to buy it.
The correlation of PGE Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as PGE Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if PGE Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for PGE Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Alder BioPharmaceuticals information on this page should be used as a complementary analysis to other Alder BioPharmaceutica's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Alder Stock
If you are still planning to invest in Alder BioPharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alder BioPharmaceutica's history and understand the potential risks before investing.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |